NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)
NT trends in ecstasy and related drug markets; Reports; PublicationNT
2011
Made available via the Publications (Legal Deposit) Act 2004 (NT).
Date:2011; Australian drug trends series No. 80
English
Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals
National Drug and Alcohol Research Centre, University of New South Wales
Sydney (N.S.W)
9780733430206
Check within Publication or with content Publisher.
https://hdl.handle.net/10070/242182
https://hdl.handle.net/10070/610318
75 6.4.3 Blood-borne viral infections Notifications of new cases of hepatitis B (HBV) and hepatitis C (HCV) to the National Notifiable Diseases Surveillance System have increased from 2010 rates, with new HCV notifications in 2011 similar to those reported in 2008 (Table 58). HIV notifications in 2010 decreased to 6 with 2011 figures as yet unavailable. Table 58: Total notification of HBV, HCV and HIV, 2000-2011 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 HBV (incident) (n) 6 3 12 15 8 5 11 12 8 4 3 5 HCV (unspecified) (n) 191 212 200 218 259 256 263 220 206 161 172 207 HIV new cases (n) 3 3 8 5 8 3 11 6 11 16 6 NA Source: NNDSS & NCHECR * NA = not available The 2010 finger-prick survey carried out in Darwin and Alice Springs, auspiced by the National Centre in HIV Epidemiology and Clinical Research (NCHER), again did not identify any individuals with HIV antibodies (Table 59). However, HCV antibody prevalence increased. Table 59: HIV and HCV antibody prevalence in NSP survey respondents, 1999-2009 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 HIV antibody (%/n) 4 (79) 1 (90) 0 (79) 0 (47) 1 (61) 0 (16) 0 (24) 0 (20) 0 (29) 1 (73) 0 (76) 0 (78) HCV antibody (%/n) 49 (79) 38 (91) 50 (84) 29 (47) 29 (62) 9 (16) 12 (24) 5 (17) 18 (29) 38 (72) 29 (75) 47 (78) Source: NCHECR 6.4.4 Self-reported injection-related health problems Figure 48 demonstrates that in 2011 78% of participants reported morphine as the drug most often injected in the six months prior to interview (91% in 2010). As in previous years, morphine was the substance most commonly recently injected by the IDRS sample. Some form of methamphetamine was the next drug most likely to have been injected (51% in 2011 compared to 34% in 2010). Recent injection of benzodiazepines doubled from 11% of participants in 2010 to 22% in 2011.